Faculty

Gerard T. Berry, M.D. - Boston Children's Hospital
Frederick Bieber, Ph.D. - Brigham and Women's Hospital
Gerald Cox, M.D. - Boston Children's Hospital
Paola Dal Cin, Ph.D. - Brigham and Women's Hospital
Natasha Frank, M.D. - Brigham and Women's Hospital
Birgit Funke, Ph.D. - Partners HealthCare Personalized Medicine
Judy Garber, M.D. - Dana Farber Cancer Institute
Anne Giersch, Ph.D. - Brigham and Women's Hospital

Robert Green, M.D. - Brigham and Women's Hospital
David Harris, M.D. - Boston Children's Hospital
Ingrid Holm, M.D. - Boston Children's Hospital
Lewis B. Holmes, M.D. - Massachusetts General Hospital
Harvey Levy, M.D. - Boston Children's Hospital
Azra Ligon, Ph.D. - Brigham and Women's Hospital
Angela Lin, M.D. - Massachusetts General Hospital

Neal Lindeman, M.D. - Brigham and Women's Hospital
Deborah Marsden, M.D. - Boston Children's Hospital

Mayra Martinez-Ojeda, M.D. - Boston Children's Hospital
Heather Mason-Suares, P.D. - Partners HealthCare Personalized Medicine

David Miller, M.D., Ph.D. - Boston Children's Hospital
Cynthia Morton, Ph.D. - Brigham and Women's Hospital
Edward Neilan, M.D., Ph.D. - Boston Children's Hospital
Jonathan Picker, M.D. - Boston Children's Hospital

Heidi Rehm, Ph.D. - Partners HealthCare Personalized Medicine
Amy Roberts, M.D. - Boston Children's Hospital
Yiping Shen, Ph.D. - Boston Children's Hospital
Katherine Sims, M.D. - Massachusetts General Hospital

Brian Skotko, M.D. - Massachusetts General Hospital
Sharon Smith, M.D. - Boston Children's Hospital
Joan Stoler, M.D. - Boston Children's Hospital
David Sweetser, M.D. - Massachusetts General Hospital
Wen-Hann Tan, M.D. - Boston Children's Hospital
Joseph Thakuria, M.D. - Massachusetts General Hospital
Christopher Walsh, M.D., Ph.D. - Boston Children's Hospital
Stanislawa Weremowicz, Ph.D. - Brigham and Women's Hospital
Louise Wilkens-Haug, M.D. - Brigham and Women's Hospital
Bai-Lin Wu, Ph.D. - Boston Children's Hospital
Winnie Xin, Ph.D. - Massachusetts General Hospital
 

 

 
Gerard T. Berry, M.D.

Director, Medical Biochemical Genetics Residency; Co-Director, Clinical Biochemical Genetics Fellowship
Gerard T. Berry, M.D. is co-director of the Clinical Biochemical Genetics program and director of the Medical Biochemical Genetics program. Dr. Berry specializes in biochemical genetics (metabolism). He is the Director of the Metabolism Program at Children’s Hospital Boston and Professor of Pediatrics at Harvard Medical School. Dr. Berry holds Board Certifications in Pediatrics, Biochemical Genetics, and Pediatric Endocrinology.

 

 

 
Frederick Bieber, Ph.D.

Cytogenetics
Frederick Bieber, Ph.D. is faculty at Brigham and Women's Hospital.

 

 

 
Gerald Cox, M.D.

Clinical Genetics
Gerald Cox is faculty at Boston Children's Hospital.

 

 

 
Paola Dal Cin, Ph.D.

Cytogenetics
Paola Dal Cin, Ph.D. is faculty at Brigham and Women's Hospital

 

 

 
Natasha Frank, M.D.

Interim Director, Internal Medicine/Medical Genetics Residency; Interim Site Director, Brigham and Women's Hospital Rotation
Natasha Frank, M.D. is a faculty member at Brigham and Women's Hospital.

 

 

 
Birgit Funke, Ph.D.

Molecular Genetics
Dr. Funke is an Associate Laboratory Director at the Laboratory for Molecular Medicine (LMM), the clinical diagnostic laboratory for Partners Personalized Medicine as well as an as Instructor of Pathology at Harvard Medical School. She oversees genetic testing and test development in the area of cardiovascular disease diseases (inherited cardiomyopathies and congenital cardiovascular malformations). Her goal is to further define the genetic basis for these disorders and to develop comprehensive tests by using new emerging molecular technologies.

 

 

 
Judy Garber, M.D.

Director, of Cancer Genetics and Prevention Disease Center Dana-Farber Cancer Institute
Judy E. Garber, M.D., MPH, is Director of the new Cancer Genetics and Prevention Disease Center at the Dana-Farber Cancer Institute. She is attending physician at Dana-Farber’s Breast Oncology Center, an associate physician at Brigham and Women’s Hospital and an associate professor of Medicine at Harvard Medical School. Dr. Garber is currently president-elect of American Association for Cancer Research, the largest organization of cancer researchers in the world. She is a member of the NCI Board of Scientific Counselors and chairs the External Advisory Board of the SPORE in Breast Cancer at MD Anderson Cancer Center. She serves on the Scientific Advisory Board of the Breast Cancer Research Foundation and is a member or chair of the Data Safety Monitoring Committees of several international breast cancer clinical trials. Locally, she co-chairs a Dana-Farber/Harvard Cancer Center Institutional Review Board panel D, and is a member of the Personalized Cancer Medicine Partnership Steering Committee and Executive Committee for Clinical Research. To foster the incorporation of cancer genetics into clinical practice, Dr. Garber has played a major role in the development of national guidelines in genetics (American College of Medical Genetics) and medical oncology (American Society of Clinical Oncology and National Comprehensive Cancer Network.) Her research activities include the study of breast cancer risk assessment and communication, cancer genetics more broadly, and pharmacogenetics. She is also a leader in research into the characteristics and treatment of triple negative or basal-like breast cancer, the most common form in women with BRCA1 mutations. Her translational research focuses on the evaluation of novel agents targeting DNA repair defects in breast cancer, including PARP inhibitors for treatment and prevention of breast cancer and other BRCA-associated cancers.

 

 

 
Anne Giersch, Ph.D.

Cytogenetics
Anne Giersch, Ph.D. is a faculty member at Brigham and Women's Hospital

 

 

 
David Harris, M.D.

Clinical Genetics Boston Children's Hospital
http://specialists.childrenshospital.org

 

 

 
Ingrid Holm, M.D.

Clinical Genetics
Ingrid Holm is a faculty member at Boston Children's Hospital http://specialists.childrenshospital.org

 

 

 
Lewis B. Holmes, M.D.

Clinical Genetics
Massachusetts General Hospital

 

 

 
Harvey Levy, M.D.

Co-Director, Clinical Biochemical Genetics Fellowship
Harvey Levy, M.D. is co-director of the HMS ABMG Clinical Biochemical Genetics program. Dr. Levy specializes in biochemical genetics (metabolism). He is Senior Physician in Medicine/Genetics at Children's Hospital Boston and Professor of Pediatrics at the Harvard Medical School. He was formerly Director of the Metabolic Program and currently serves as an attending physician within the program. Dr. Levy conducts clinical research in two areas of metabolism, phenylketonuria (PKU) and clinical and biochemical follow-up of newborn screening for metabolic disorders. He has very active research projects ongoing in those areas.

 

 

 
Azra Ligon, Ph.D.

Director, Cytogenetics Fellowship Fellowship
Azra H. Ligon, Ph.D., oversees training in the HMS ABMG Clinical Cytogenetics program. Dr. Ligon received her Ph.D. in Cancer Biology from the University of Texas/M.D. Anderson Cancer Center in 1995. She completed her Medical Genetics training at Baylor College of Medicine in 1997 and, after a research postdoctoral fellowship at Brigham and Women's Hospital (BWH), joined the Staff of the BWH Cytogenetics Laboratory in 1999 as an ABMG-certified Clinical Cytogeneticist. In 2003, she assumed leadership of the HMS ABMG Cytogenetics training program. Dr. Ligon's research activities include translation of basic research findings into clinical diagnostics, especially those relevant to the area of cancer diagnostics.

 

 

 
Angela Lin, M.D.

Clinical Genetics, Massachusetts General Hospital
Angela Lin trained in pediatric cardiology and medical genetics. As a clinical geneticist at MassGeneral Hospital for Children, her general genetics clinic is on Friday morning, supplemented by Cardiogenetics Clinic (including the MGH HHT Service), Craniofacial Clinic, Turner Syndrome Clinic, CHARGE Syndrome Clinic, and her interest in Costello and related Ras/MAPK syndromes. She works in the Active Malformation Surveillance Program at the BWH, and works at the MA Dept. Public Health as the geneticist for the Massachusetts Center for Birth Defects Prevention. Her clinical research interest focuses on syndrome delineation, cardiovascular anomalies in syndromes, and the epidemiology of CHDs. Dr. Lin is an Associate Editor for the American Journal of Medical Genetics. She works with several consumer advocacy groups including the Costello Syndrome Family Network and Turner Syndrome Society of America.

 

 

 
Cynthia Morton, Ph.D.

Education Director
Cynthia Morton, Ph.D. is the William Lambert Richardson Professor of Obstetrics, Gynecology and Reproductive Biology and Professor of Pathology at Harvard Medical School, Associate Director of the Partners HealthCare Center for Personalized Genetic Medicine, Education Director for the HMS Genetics Training Program and Director of Cytogenetics at Brigham and Women's Hospital. Her research interests are in molecular cytogenetics, hereditary deafness, genetics of uterine leiomyomata, hereditary hearing loss, and cytogenetic approaches to gene discovery for developmental disorders. Her full-time academic laboratory contributed to the development of diagnostic testing for chromosome studies that cross the lifespan, which include preimplantation and prenatal diagnostics, perinatal and childhood studies in the evaluation of congenital and developmental disorders, infertility and pregnancy loss studies, and cytogenetics of leukemias, lymphomas and solid tumors. Her laboratory has been a major site for training laboratory geneticists in clinical cytogenetics.

 

 

 
Heidi Rehm, Ph.D.

Director, Molecular Genetics Fellowship
Heidi Rehm was recruited in 2001 to build the Laboratory for Molecular Medicine at Partners Personalized Medicine and now serves as its Laboratory Director. She is a board-certified clinical molecular geneticist and Assistant Professor of Pathology at Harvard Medical School with appointments at Brigham & Women’s Hospital, Massachusetts General Hospital and Children’s Hospital Boston. Her undergraduate degree is from Middlebury College, her graduate degree in Genetics is from Harvard University and her postdoctoral and fellowship training was at Harvard Medical School. Heidi has served as the Director of the ABMG Clinical Molecular Genetics Training Program at Harvard Medical School since 2006. In addition to running the LMM and the molecular training program, she also conducts research in hearing loss, Usher syndrome, cardiomyopathy and the use of IT in enabling personalized medicine.

 

 

 
Amy Roberts, M.D.

Co-Director, Pediatrics/Medical Genetics Residency; Co-Director, Maternal Fetal Medicine/Medical Genetics Fellowship
Amy Roberts, M.D., CHB Department of Cardilogy and Department of Medicine, Division of Genetics Dr. Roberts is a cardiovascular clinical geneticist and supervises trainees in the clinic and on the inpatient consult service. She also teaches in the Advanced Human Genetics course. She is conducting research on genotype-phenotype correlations in Noonan syndrome and congenital heart disease gene discovery. She co-directs the combined Pediatrics/Clinical Genetics residency training program with Ted Sectish, MD, Children's Hospital Boston.

 

 

 
Christopher Walsh, M.D., Ph.D.

Dr. Walsh is the Chief of the Division of Genetics at Children's Hospital Boston as well as Professor of Neurology and Pediatrics at Harvard Medical School, Associate Member of the Broad Institute, and Senior Associate in Neurology at Beth Israel Deaconess Medical Center. Dr. Walsh is interested in genes that regulate the development and function of the human cerebral cortex. More information can be found here: www.walshlab.org